# Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)

> **NCT00116571** · PHASE2 · TERMINATED · sponsor: **QLT Inc.** · enrollment: 180 (—)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Lemuteporfin for injection
- **DEVICE:** Transurethral drug delivery system
- **DEVICE:** Transurethral light delivery system

## Key facts

- **NCT ID:** NCT00116571
- **Lead sponsor:** QLT Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 180 (—)
- **Last updated:** 2006-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116571, "Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00116571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*